FINVX | GSIKX | FINVX / GSIKX | |
Total Expense Ratio | 0.01 | 0.84 | 1% |
Annual Report Gross Expense Ratio | 0.01 | 0.89 | 1% |
Fund Existence | 16 years | 18 years | - |
Gain YTD | 28.104 | 19.358 | 145% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 16B | 2.71B | 591% |
Annual Yield % from dividends | 3.64 | 2.56 | 142% |
Returns for 1 year | 23.82 | 19.00 | 125% |
Returns for 3 years | 78.06 | 62.96 | 124% |
Returns for 5 years | 116.61 | 89.58 | 130% |
Returns for 10 years | 93.14 | 91.70 | 102% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LABU | 61.54 | 0.84 | +1.38% |
Direxion Daily S&P Biotech Bull 3X ETF | |||
XUSP | 42.77 | 0.53 | +1.25% |
Innovator Uncapped Accelerated US Eq ETF | |||
FVD | 45.48 | 0.12 | +0.26% |
First Trust Value Line® Dividend ETF | |||
TAXX | 50.58 | N/A | -0.01% |
BondBloxx IR+M Tax-Awr Shrt Dur ETF | |||
INEQ | 35.62 | -0.12 | -0.34% |
Columbia Intl Equ Income ETF |